nVerses Capital »

4d Molecular Therapeutics In shares owned by nVerses Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $94k 10k 9.31
2024-09-30 $40k 3.7k 10.81

More positions owned by nVerses Capital

Lam Research Corp Com New (LRCX)
Ally Financial (ALLY)
Comfort Systems USA (FIX)
Intuitive Surgical Com New (ISRG)
Cintas Corporation (CTAS)
Owl Rock Capital Corporation (OBDC)
Stryker Corporation (SYK)
Jefferies Finl Group (JEF)
Atmus Filtration Technologies Ord (ATMU)
Tsakos Energy Navigation SHS (TEN)
Docusign (DOCU)
A10 Networks (ATEN)
Domino's Pizza (DPZ)
Arista Networks Com Shs (ANET)
Cincinnati Financial Corporation (CINF)

View all positions for nVerses Capital

Top funds holding 4d Molecular Therapeutics In

Henderson Group
RA Capital Management
Goldman Sachs Group
BlackRock
Novo A/S
Vanguard Group
BVF
State Street Corporation
Armistice Capital
Federated Investors
Trails Edge Capital Partners
Adage Capital Partners GP
Geode Capital Management
Bank of America Corporation
Evergreen Quality Fund GP

View all funds holding 4d Molecular Therapeutics In